Genesys Logic, Inc. (TPEX:6104)

SpringWorks Therapeutics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,325	1,244	1,110	692.32	841.85	519.72
Short-Term Investments	5.68	5.28	2.13	1.17	0.43	0.12
Cash & Short-Term Investments	1,330	1,249	1,112	693.49	842.27	519.84
Cash Growth	12.29%	12.34%	60.33%	-17.66%	62.02%	-12.22%
Accounts Receivable	361.55	285.51	201.65	217.4	337.19	258.03
Receivables	361.55	285.51	201.65	217.4	337.19	258.03
Inventory	555.55	382.45	627.37	1,360	960.64	506.47
Prepaid Expenses	115.33	119.8	77.48	70.07	59.34	54.18
Other Current Assets	108.87	103.27	0.97	4.16	283.24	180.04
Total Current Assets	2,472	2,140	2,019	2,345	2,483	1,519
Property, Plant & Equipment	929.52	934.85	943.95	938.05	960.56	963.05
Long-Term Investments	73.38	74	9.57	2.13	4.39	5.56
Other Intangible Assets	57.49	62.1	74.3	79.55	101.23	106.1
Long-Term Deferred Tax Assets	60.27	60.33	59.77	39.88	12.39	13.39
Other Long-Term Assets	28.5	21.1	41.34	18.13	9.98	13.58
Total Assets	3,621	3,292	3,148	3,423	3,571	2,620
Accounts Payable	302.98	239.88	166.53	135.09	450.87	269.19
Accrued Expenses	191.09	210.28	152.34	228.96	215.17	282.77
Short-Term Debt	269	229	401	498.5	850	450
Current Portion of Long-Term Debt	435.72	454.73	-	-	-	-
Current Portion of Leases	4.75	5.05	4.49	2.36	2.37	2.4
Current Unearned Revenue	25.27	22.62	10.72	15.31	7.89	10.63
Other Current Liabilities	414.41	120.26	108.41	125.92	143.59	-
Total Current Liabilities	1,643	1,282	843.48	1,006	1,670	1,015
Long-Term Debt	-	-	467.02	458.27	-	-
Long-Term Leases	3.14	4.07	7.27	-	1.94	4.25
Long-Term Deferred Tax Liabilities	-	1.2	0.01	-	0.01	0.01
Other Long-Term Liabilities	6.22	3.86	6.94	14.62	5.08	-
Total Liabilities	1,653	1,292	1,327	1,483	1,684	1,051
Common Stock	910.28	908.54	902.79	902.79	902.79	902.79
Additional Paid-In Capital	353.16	333.06	315.76	269.24	229.21	229.17
Retained Earnings	774.15	831.61	687.83	813.93	801.07	493.01
Comprehensive Income & Other	-73.97	-76.91	-89.19	-50.21	-49.57	-56.87
Total Common Equity	1,964	1,996	1,817	1,936	1,884	1,568
Minority Interest	4.51	4.3	4.37	3.82	3.95	0.88
Shareholders' Equity	1,968	2,001	1,822	1,940	1,887	1,569
Total Liabilities & Equity	3,621	3,292	3,148	3,423	3,571	2,620
Total Debt	712.61	692.85	879.78	959.13	854.31	456.65
Net Cash (Debt)	617.64	556.23	232.11	-265.64	-12.03	63.2
Net Cash Growth	103.82%	139.64%	-	-	-	-79.51%
Net Cash Per Share	6.45	5.88	2.56	-2.88	-0.13	0.69
Filing Date Shares Outstanding	91.03	90.85	90.28	90.28	90.28	90.28
Total Common Shares Outstanding	91.03	90.85	90.28	90.28	90.28	90.28
Working Capital	828.34	858.29	1,176	1,339	812.79	503.56
Book Value Per Share	21.57	21.97	20.13	21.44	20.86	17.37
Tangible Book Value	1,906	1,934	1,743	1,856	1,782	1,462
Tangible Book Value Per Share	20.94	21.29	19.31	20.56	19.74	16.19
Land	573.31	573.31	573.31	573.31	573.31	573.31
Buildings	414.02	414.02	411.91	411.52	410.2	408.02
Machinery	813.67	798.29	732.49	746.14	699.96	632.43

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.